Loading asset research
Freenome Inc. Common stock
FRNMNasdaq · USD · StocksQuote as of · Exchange session not verified$15.77
+0.48%
Today
FRNM
Loading 1D prices…
Market cap
$1.7B
Volume
507.8K
52w high
$17.5052w low
$9.95Company profile
Freenome Inc. Common stock
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Sector
Health Care
Industry
Services-Medical Laboratories
Exchange
Nasdaq
Display currency
USD
Location
Brisbane, CA, United States
Employees
375
Fiscal year end
1231
CIK
2017526
Session & valuation
Open$15.57
Previous close$15.70
Day high$16.17
Day low$15.28
30-day avg. volume1M
Outstanding shares8.9M
Diluted EPS-$2.65
Latest annual period
P/E (trailing)-5.95
P/E (forward)-6.67
Price / book-0.30
Beta0.48
Dividend yield—
Deterministic peer set
Companies with SEC SIC 8071
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PSNLPersonalis Inc. Common Stock | $1.8B | $69.6M | -116.69% | -$0.91 | +1.35% | Hold |
| FTREFortrea Holdings Inc. Common Stock | $1.9B | $2.7B | -36.31% | -$10.81 | +2.56% | Hold |
| CSTLCastle Biosciences Inc. Common Stock | $1.1B | $344.2M | -7.02% | -$0.83 | +0.89% | Buy |
| LMRILumexa Imaging Holdings Inc. Common Stock | $949.2M | $1B | -4.60% | -$0.66 | -2.56% | Buy |
| CDNACareDx Inc. Common Stock | $3.2B | $379.8M | -5.62% | -$0.40 | +17.37% | Buy |